Generally, good candidates for semaglutide are overweight (25+ BMI) and would like to lose weight to improve their health and appearance, or to get to a healthy, stable weight to be eligible for a surgical procedure
Retatrutide is currently being evaluated in multiple Phase 3 clinical trials globally, including studies comparing it with other treatments and examining long-term safety and effectiveness
Below are known side effects of semaglutide, which are primarily GI related
Indeed, loss of GPX4 expression and activity specifically in monocytes/macrophages triggers ferroptosis in IL-4-driven macrophage differentiation, while sparing inflammatory macrophages, which were able to sustain cell survival and function in the absence of GPX4
Sensitivity analyses using leave-one-out models and exclusion of high-risk-of-bias studies confirmed the robustness of the findings, as the direction and magnitude of effects remained unchanged across iterations
Underlying Gastrointestinal Conditions: SIBO can be secondary to other gastrointestinal disorders, such as irritable bowel syndrome (IBS), celiac disease, Crohns disease, or gastroparesis
